Dr. Elyse Kemmerer White is a Scientific Program Manager for the Blueprint MedTech Program in the Division of Translational Research at the National Institute for Neurological Disorders and Stroke (NINDS). She received her B.S. in Behavioral Neuroscience from Lehigh University and her Ph.D. in Neuroscience from the University of Michigan, studying disease-modifying strategies for nigrostriatal degeneration in Parkinson’s disease. Following a Post-doc in Psychiatry, she completed an interdisciplinary training fellowship in Medical Device Innovation, also at the University of Michigan. Dr. White co-founded Tangent Medical Technologies to commercialize a Class II intravenous access device she and her fellowship team invented in response to unmet clinical needs. She led fundraising and business planning efforts that led to > $25 Million in Angel and Venture Capital funding and worked with the team to translate the product concept out of the university to international sales. The company was acquired by ICU Medical in 2016. Since then, Dr. White has served as Chief Science Officer of multiple private equity-backed health tech startup companies and mentored a variety of early-stage med tech companies in the community, including involvement with national and regional iCorps programs and more recently as an Entrepreneur-in-Residence at Michigan State University.